These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8222924)

  • 1. [Gene therapy of malignant tumors].
    Schackert HK; Frost P
    Chirurg; 1993 Sep; 64(9):678-83. PubMed ID: 8222924
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined tumor chemotherapy/gene therapy based on the activation of antineoplastic agents by genetic constructions of cytochromes p450].
    Sokolova NN; Iatsenko AN; Pokrovskaia MV
    Vopr Med Khim; 1999; 45(6):462-71. PubMed ID: 10761211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [P53 protein: a new tool for the clinician?].
    Laurent-Puig P
    Gastroenterol Clin Biol; 1995 May; 19(5):463-4. PubMed ID: 7589996
    [No Abstract]   [Full Text] [Related]  

  • 4. The etiology of human cancers.
    Kleihues P
    Prev Med; 1996; 25(1):13. PubMed ID: 8778752
    [No Abstract]   [Full Text] [Related]  

  • 5. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
    Wiman KG
    Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways.
    Kühnel F; Zender L; Wirth T; Schulte B; Trautwein C; Manns M; Kubicka S
    Cancer Gene Ther; 2004 Jan; 11(1):28-40. PubMed ID: 14681724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [p53 and hepatocellular carcinomas].
    Mihm S; Leonhardt U; Ramadori G
    Z Gastroenterol; 1993 Sep; 31(9):498-9. PubMed ID: 8237091
    [No Abstract]   [Full Text] [Related]  

  • 8. p53: prospects for cancer gene therapy.
    Soddu S; Sacchi A
    Cytokines Cell Mol Ther; 1998 Sep; 4(3):177-85. PubMed ID: 9825843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular therapy for cancer.
    Deisseroth A; Guo D; Wang T; Fujii T; Fu SQ; Cote R; Savinov S; Liu F; Loewe R; Pizzorno G; Austin D; Crystal R; Chung I
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S5-7. PubMed ID: 9619264
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting gene expression to tumor cells with loss of wild-type p53 function.
    Zhu J; Gao B; Zhao J; Balmain A
    Cancer Gene Ther; 2000 Jan; 7(1):4-12. PubMed ID: 10678350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
    Roa I; Villaseca M; Araya JC; Roa J; de Aretxabala X; Fuentealba P; Melo A
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):547-50. PubMed ID: 9232344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative immunohistochemical staining of p53 protein does not always reflect wild-type p53 gene in cancer cells.
    Horiuchi H; Kawamata H; Omotehara F; Fujii S; Fujimori T; Kuroda Y
    J Gastroenterol; 2004 Aug; 39(8):801-3. PubMed ID: 15338377
    [No Abstract]   [Full Text] [Related]  

  • 13. [The p53 gene and protein in 2005: new results, promising opportunities].
    Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
    Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.
    Tanaka Y; Ota K; Kameoka M; Itaya A; Yoshihara K
    Exp Cell Res; 2006 May; 312(8):1254-64. PubMed ID: 16430884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and response to chemotherapy and radiotherapy.
    Ruley HE
    Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127
    [No Abstract]   [Full Text] [Related]  

  • 16. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
    Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
    Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [p53 mutations and their role in tumorigenesis].
    Tsuchida N; Munirajan AK
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1567-75. PubMed ID: 9279083
    [No Abstract]   [Full Text] [Related]  

  • 18. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
    Naumann U; Kügler S; Wolburg H; Wick W; Rascher G; Schulz JB; Conseiller E; Bähr M; Weller M
    Cancer Res; 2001 Aug; 61(15):5833-42. PubMed ID: 11479223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for enhancing viral-based gene therapy using ionizing radiation.
    Chmura SJ; Advani SJ; Kufe DW; Weichselbaum RR
    Radiat Oncol Investig; 1999; 7(5):261-9. PubMed ID: 10580895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 in epidermoid cancer of the esophagus.
    Tanaka M; Nonogaki S; Alberti VN; Forones NM
    Hepatogastroenterology; 1999; 46(27):1765-8. PubMed ID: 10430340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.